CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $871,000 | -6.5% | 72,200 | -2.8% | 0.01% | -23.1% |
| Q4 2018 | $932,000 | +144.6% | 74,300 | +189.1% | 0.01% | +225.0% |
| Q3 2018 | $381,000 | -8.4% | 25,700 | +4.0% | 0.00% | -20.0% |
| Q2 2018 | $416,000 | +99.0% | 24,700 | +64.7% | 0.01% | +66.7% |
| Q2 2017 | $209,000 | -76.1% | 15,000 | -70.8% | 0.00% | -72.7% |
| Q1 2017 | $875,000 | +375.5% | 51,300 | +186.6% | 0.01% | +266.7% |
| Q4 2016 | $184,000 | +7.6% | 17,900 | +5.9% | 0.00% | +50.0% |
| Q3 2016 | $171,000 | – | 16,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |